Back to Rheumatology
Rheumatologyv2006Evidence-Based

CASPAR Criteria for Psoriatic Arthritis

Provides standardized classification criteria for identifying psoriatic arthritis (PsA) in patients with inflammatory arthritis. Requires presence of inflammatory articular disease plus ≥3 points from additional criteria.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
caspar classification
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CASPAR Criteria for Psoriatic Arthritis is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within rheumatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CASPAR Classification requires: 1) Inflammatory articular disease (mandatory) PLUS 2) ≥3 points from: Current psoriasis (2 pts), History of psoriasis (1 pt), Nail dystrophy (1 pt), RF negative (1 pt), Dactylitis (1 pt), Juxtaarticular new bone formation (1 pt)

Clinical Pearls & Practice Notes

  • CASPAR criteria are classification criteria, not diagnostic criteria
  • Designed primarily for research and clinical trial patient selection
  • Sensitivity: 91%, Specificity: 98%
  • Requires mandatory presence of inflammatory articular disease
  • Current psoriasis scores 2 points; all other features score 1 point
  • Developed from international study of 588 PsA patients across 30 clinics
  • Personal or family history of psoriasis counts as 1 point (if no current psoriasis)
  • Nail dystrophy includes onycholysis, pitting, and hyperkeratosis
  • Dactylitis can be current or historical
  • Juxtaarticular new bone formation seen on X-ray of hands or feet
  • RF negativity preferred by ELISA or nephelometry methods
  • Should be used in conjunction with clinical judgment
  • Not intended as standalone diagnostic tool for individual patients

Evidence & Literature Citations

  1. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006 Aug;54(8):2665-73. doi: 10.1002/art.21972.
  2. Chandran V, Schentag CT, Gladman DD. Sensitivity and specificity of the CASPAR criteria for psoriatic arthritis in a family medicine clinic setting. J Rheumatol. 2008 Oct;35(10):2069-70.
  3. Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii3-8. doi: 10.1136/ard.2004.032318.

Score Interpretation Ranges

Does Not Meet CASPAR Criteria0 – 2 pts

Insufficient criteria for psoriatic arthritis classification

Meets CASPAR Criteria3 – 6 pts

Meets criteria for psoriatic arthritis classification

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.